Barrage Khalil 4
4 · Protagenic Therapeutics, Inc.\new · Filed Oct 18, 2017
Insider Transaction Report
Form 4
Barrage Khalil
Director
Transactions
- Award
Non-Qualified Stock Options (Right to Buy)
2017-10-16+45,000→ 45,000 totalExercise: $1.75Exp: 2027-10-16→ Protagenic Therapeutics, Inc. Common Stock (45,000 underlying)
Footnotes (1)
- [F1]Vesting in equal installments over 18 months